← We Can Medicines Co. overview

We Can Medicines Co. vs Sprouts Farmers Market LLC: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

We Can Medicines Co., Ltd. (6929.TWO)

Sprouts Farmers Market LLC (SFM)

Q3 2026
▲2▼2

Sprouts' Q2 Beat Fades as Weak Guidance and Comps Drop Weigh

  • Q2 earnings beat and raised full-year outlook Sprouts beat Q2 estimates with $1.37 EPS and 5% sales growth, then raised full-year sales and EPS guidance. The stock jumped 16% on the news, as investors focused on new stores and a long-term path to over 1,000 locations.

    This is the main positive force behind SFM's move this period, driving the initial surge.

  • Weak next-quarter and full-year EPS guidance Despite the Q2 beat, Sprouts guided next-quarter EPS to $1.20-$1.24, below the $1.37 just reported, and full-year guidance missed expectations. This disappointed investors and later sent shares down 17.1%, as future profits look weaker than hoped.

    This is the key negative driver that reversed the initial rally and explains the subsequent decline.

  • Comparable store sales decline 1% Sprouts' same-store sales fell 1% in Q2, meaning existing stores sold less than a year ago. Management blamed tough comparisons, a challenging consumer, and a Cyclospora outbreak. This signals weaker demand at current locations, pressuring the stock.

    This is a core operational weakness that weighs on SFM's valuation and investor sentiment.

  • New product launch and CEO succession Sprouts launched LivReal energy drink nationwide to drive traffic and basket size, and named Nick Konat as next CEO starting January 2027. Both are strategic moves that could support future growth, though their near-term impact is uncertain.

    These are new developments that could influence SFM's long-term direction and investor perception.

August 2026
▲2▼2

Sprouts' Q2 Beat Fades as Weak Guidance and Comps Drop Weigh

  • Q2 earnings beat and raised full-year outlook Sprouts beat Q2 estimates with $1.37 EPS and 5% sales growth, then raised full-year sales and EPS guidance. The stock jumped 16% on the news, as investors focused on new stores and a long-term path to over 1,000 locations.

    This is the main positive force behind SFM's move this period, driving the initial surge.

  • Weak next-quarter and full-year EPS guidance Despite the Q2 beat, Sprouts guided next-quarter EPS to $1.20-$1.24, below the $1.37 just reported, and full-year guidance missed expectations. This disappointed investors and later sent shares down 17.1%, as future profits look weaker than hoped.

    This is the key negative driver that reversed the initial rally and explains the subsequent decline.

  • Comparable store sales decline 1% Sprouts' same-store sales fell 1% in Q2, meaning existing stores sold less than a year ago. Management blamed tough comparisons, a challenging consumer, and a Cyclospora outbreak. This signals weaker demand at current locations, pressuring the stock.

    This is a core operational weakness that weighs on SFM's valuation and investor sentiment.

  • New product launch and CEO succession Sprouts launched LivReal energy drink nationwide to drive traffic and basket size, and named Nick Konat as next CEO starting January 2027. Both are strategic moves that could support future growth, though their near-term impact is uncertain.

    These are new developments that could influence SFM's long-term direction and investor perception.

Latest
▲2▼2

Sprouts' Q2 Beat Fades as Weak Guidance and Comps Drop Weigh

  • Q2 earnings beat and raised full-year outlook Sprouts beat Q2 estimates with $1.37 EPS and 5% sales growth, then raised full-year sales and EPS guidance. The stock jumped 16% on the news, as investors focused on new stores and a long-term path to over 1,000 locations.

    This is the main positive force behind SFM's move this period, driving the initial surge.

  • Weak next-quarter and full-year EPS guidance Despite the Q2 beat, Sprouts guided next-quarter EPS to $1.20-$1.24, below the $1.37 just reported, and full-year guidance missed expectations. This disappointed investors and later sent shares down 17.1%, as future profits look weaker than hoped.

    This is the key negative driver that reversed the initial rally and explains the subsequent decline.

  • Comparable store sales decline 1% Sprouts' same-store sales fell 1% in Q2, meaning existing stores sold less than a year ago. Management blamed tough comparisons, a challenging consumer, and a Cyclospora outbreak. This signals weaker demand at current locations, pressuring the stock.

    This is a core operational weakness that weighs on SFM's valuation and investor sentiment.

  • New product launch and CEO succession Sprouts launched LivReal energy drink nationwide to drive traffic and basket size, and named Nick Konat as next CEO starting January 2027. Both are strategic moves that could support future growth, though their near-term impact is uncertain.

    These are new developments that could influence SFM's long-term direction and investor perception.